Provectus Biopharmaceuticals Inc (PVCT)

[vorlon1966]

My Response to the Disclosed Short and his Article

By Jkrywyn_John posted on Investor Village

If you notice he is short. He also uses not facts but tries to use circumstantial evidence and he tries to use insinuations. Not accusations.


1. Four employees: There is no argument there. To insinuate that a company with four employees means anything negative is ridiculous. MULTIPLE cancer centers are doing clinical studies. The FDA designated PV-10 orphan drug status and they are under compassionate use CUP program. They work at the Oak Ridge National Lab.

2. PVCT is not “connected” to paid stock promoters. This guy uses anecdotal evidence of other companies and tries in a a roundabout way to connect them to Provectus. Not true. No facts to support this.

3 PVCT has worked with an SPA for Phase 3 with the FDA and were ready to proceed. Then the FDA radically changed their structuring. Essentially, the FDA reshuffled their organization and management was working with CDER for SPA (who had no experience with local agents and SPA for melanoma, according to the blog). Management and consultants thought they would get SPA summer 2011.

The CCDER and CBER staff were "reshuffled into DOP1 and DOP2 (division of oncology products)


Essentially, the people they dealt with changed. Then, as they likely got back on track (they suggested it set them back a year), in early 2013 BTD became an option.

BTD would get the drug to market faster so they are pursuing that and have had a cooperative working relationship with the FDA

4. To suggest they had PH-10 and PV-10 in their last company - also a lie. They were a laser company.

5. Compensation is in line with other pharmaceuticals. Also - nothing there but anecdote and insinuations.

6. PVCT is a biotech startup. Average companies brining a cancer drug to market take over $1 billion dollars and ten years. They have been working quicker and have used well under $200 million. They have been working with several hospitals - the leaden in cancer research including Anderson and Moffitt. Most startups, unfortunately, don’t get favorable financing. They had to use Network 1 and no longer do.


7. PVCT has not made claims. They have shown data and clinical researcher and the most renown doctors and cancer hospitals have shown data. This guy says nothing about data but linking to Adam F who has also never refuted the data. He has also claimed he bashes PVCT for “Sport"

Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt's excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the No. 1 cancer hospital in Florida and has been listed in U.S. News & World Report as one of "America's Best Hospitals" for cancer since 1999. With more than 4,200 employees, Moffitt has an economic impact on the state of nearly $2 billion


http://www.pvct.com/news/PV-10-EADO-2014-May.pdf

look at the data

8. The recent changes were being pointed out by SALLY CHURCH and myself @jkrywyn on twitter contacted management. There has been no decision and you do not and cannot know that until the FDA announces. I think you’re mentally challenged. make it true. They made the changes to the website and Adam F went ahead and wrote the article he was insinuating he would right saying it was false advertising. He wrote it anyway making (again - a baseless one) an insinuation that this meant something or another.

9. It’s impossible to be worth $0 when your company has $18 million in cash. The company has a blockbuster drug and those who were not scared out or shaken out stand to profit when more progress is made.


Lastly:

In 2006 his father’s account purchased and profited $14,000. Dr. Argawala paid a fine and he has recently disclaimed not to own any Provectus shares. He had made a mistake before this company was even an idea in his mind. Again. A reaching insinuation. No fact.

http://www.sec.gov/litigation/litreleases/lr19568.htm